Tech Company Financing Transactions
Electra Therapeutics Funding Round
Electra Therapeutics, based in South San Francisco, raised $84 million from OrbiMed and Westlake Village BioPartners.
Transaction Overview
Company Name
Announced On
2/25/2022
Transaction Type
Venture Equity
Amount
$84,000,000
Round
Series B
Investors
OrbiMed (Lead Investor)
Proceeds Purpose
The proceeds will bankroll a phase 1b trial of the asset, dubbed ELA026, as well as further studies testing the drug in other rare diseases, said Adam Rosenthal, Ph.D., CEO and co-founder, in an interview.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
681 Gateway Blvd
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Our mastery of SIRP-directed biology is pointing the way toward breakthrough therapies for immunological diseases and cancer
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Rosenthal
Browse more venture capital transactions:
Prev: 2/25/2022: Nth Cycle venture capital transaction
Next: 2/25/2022: Employment Hero venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC transactions on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs